106 related articles for article (PubMed ID: 21757343)
1. 6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulators.
Weiss JM; Jimenez HN; Li G; April M; Uberti MA; Bacolod MD; Brodbeck RM; Doller D
Bioorg Med Chem Lett; 2011 Aug; 21(16):4891-9. PubMed ID: 21757343
[TBL] [Abstract][Full Text] [Related]
2. Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.
Chae E; Shin YJ; Ryu EJ; Ji MK; Ryune Cho N; Lee KH; Jeong HJ; Kim SJ; Choi Y; Seok Oh K; Park CE; Soo Yoon Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):2134-9. PubMed ID: 23434029
[TBL] [Abstract][Full Text] [Related]
3. A novel series of metabotropic glutamate receptor 5 negative allosteric modulators based on a 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine core.
Duvey G; Perry B; Le Poul E; Poli S; Bonnet B; Lambeng N; Charvin D; Donovan-Rodrigues T; Haddouk H; Gagliardi S; Rocher JP
Bioorg Med Chem Lett; 2013 Aug; 23(16):4523-7. PubMed ID: 23850200
[TBL] [Abstract][Full Text] [Related]
4. Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor.
Tresadern G; Cid JM; Macdonald GJ; Vega JA; de Lucas AI; García A; Matesanz E; Linares ML; Oehlrich D; Lavreysen H; Biesmans I; Trabanco AA
Bioorg Med Chem Lett; 2010 Jan; 20(1):175-9. PubMed ID: 19932615
[TBL] [Abstract][Full Text] [Related]
5. N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators.
Packiarajan M; Mazza Ferreira CG; Hong SP; White AD; Chandrasena G; Pu X; Brodbeck RM; Robichaud AJ
Bioorg Med Chem Lett; 2012 Sep; 22(17):5658-62. PubMed ID: 22832311
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists.
Galatsis P; Yamagata K; Wendt JA; Connolly CJ; Mickelson JW; Milbank JB; Bove SE; Knauer CS; Brooker RM; Augelli-Szafran CE; Schwarz RD; Kinsora JJ; Kilgore KS
Bioorg Med Chem Lett; 2007 Dec; 17(23):6525-8. PubMed ID: 17936624
[TBL] [Abstract][Full Text] [Related]
7. SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide.
Barda DA; Wang ZQ; Britton TC; Henry SS; Jagdmann GE; Coleman DS; Johnson MP; Andis SL; Schoepp DD
Bioorg Med Chem Lett; 2004 Jun; 14(12):3099-102. PubMed ID: 15149652
[TBL] [Abstract][Full Text] [Related]
8. 2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist.
Huang D; Poon SF; Chapman DF; Chung J; Cramer M; Reger TS; Roppe JR; Tehrani L; Cosford ND; Smith ND
Bioorg Med Chem Lett; 2004 Nov; 14(22):5473-6. PubMed ID: 15482906
[TBL] [Abstract][Full Text] [Related]
9. Dipyridyl amines: potent metabotropic glutamate subtype 5 receptor antagonists.
Kamenecka TM; Bonnefous C; Govek S; Vernier JM; Hutchinson J; Chung J; Reyes-Manalo G; Anderson JJ
Bioorg Med Chem Lett; 2005 Oct; 15(19):4350-3. PubMed ID: 16039855
[TBL] [Abstract][Full Text] [Related]
10. 3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist.
Poon SF; Eastman BW; Chapman DF; Chung J; Cramer M; Holtz G; Cosford ND; Smith ND
Bioorg Med Chem Lett; 2004 Nov; 14(22):5477-80. PubMed ID: 15482907
[TBL] [Abstract][Full Text] [Related]
11. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist.
Ito S; Satoh A; Nagatomi Y; Hirata Y; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Kawamoto H; Ohta H
Bioorg Med Chem; 2008 Nov; 16(22):9817-29. PubMed ID: 18849168
[TBL] [Abstract][Full Text] [Related]
12. New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of N-propyl-8-chloro-6-substituted isoquinolones.
Trabanco AA; Duvey G; Cid JM; Macdonald GJ; Cluzeau P; Nhem V; Furnari R; Behaj N; Poulain G; Finn T; Lavreysen H; Poli S; Raux A; Thollon Y; Poirier N; D'Addona D; Andrés JI; Lutjens R; Le Poul E; Imogai H; Rocher JP
Bioorg Med Chem Lett; 2011 Feb; 21(3):971-6. PubMed ID: 21232953
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases.
Jaeschke G; Kolczewski S; Spooren W; Vieira E; Bitter-Stoll N; Boissin P; Borroni E; Büttelmann B; Ceccarelli S; Clemann N; David B; Funk C; Guba W; Harrison A; Hartung T; Honer M; Huwyler J; Kuratli M; Niederhauser U; Pähler A; Peters JU; Petersen A; Prinssen E; Ricci A; Rueher D; Rueher M; Schneider M; Spurr P; Stoll T; Tännler D; Wichmann J; Porter RH; Wettstein JG; Lindemann L
J Med Chem; 2015 Feb; 58(3):1358-71. PubMed ID: 25565255
[TBL] [Abstract][Full Text] [Related]
14. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
[TBL] [Abstract][Full Text] [Related]
15. Pyridine-derived γ-secretase modulators.
Wan Z; Hall A; Sang Y; Xiang JN; Yang E; Smith B; Harrison DC; Yang G; Yu H; Price HS; Wang J; Hawkins J; Lau LF; Johnson MR; Li T; Zhao W; Mitchell WL; Su X; Zhang X; Zhou Y; Jin Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
Bioorg Med Chem Lett; 2011 Aug; 21(16):4832-5. PubMed ID: 21742495
[TBL] [Abstract][Full Text] [Related]
16. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.
Johnson MP; Baez M; Jagdmann GE; Britton TC; Large TH; Callagaro DO; Tizzano JP; Monn JA; Schoepp DD
J Med Chem; 2003 Jul; 46(15):3189-92. PubMed ID: 12852748
[TBL] [Abstract][Full Text] [Related]
17. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
[TBL] [Abstract][Full Text] [Related]
18. Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists.
Chua PC; Nagasawa JY; Bleicher LS; Munoz B; Schweiger EJ; Tehrani L; Anderson JJ; Cramer M; Chung J; Green MD; King CD; Reyes-Manalo G; Cosford ND
Bioorg Med Chem Lett; 2005 Oct; 15(20):4589-93. PubMed ID: 16115767
[TBL] [Abstract][Full Text] [Related]
19. Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists.
Bonnefous C; Vernier JM; Hutchinson JH; Chung J; Reyes-Manalo G; Kamenecka T
Bioorg Med Chem Lett; 2005 Feb; 15(4):1197-200. PubMed ID: 15686941
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel histamine H4 receptor antagonists.
Lane CA; Hay D; Mowbray CE; Paradowski M; Selby MD; Swain NA; Williams DH
Bioorg Med Chem Lett; 2012 Jan; 22(2):1156-9. PubMed ID: 22189138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
